Cargando…

Agent Repurposing for the Treatment of Advanced Stage Diffuse Large B-Cell Lymphoma Based on Gene Expression and Network Perturbation Analysis

Over 50% of diffuse large B-cell lymphoma (DLBCL) patients are diagnosed at an advanced stage. Although there are a few therapeutic strategies for DLBCL, most of them are more effective in limited-stage cancer patients. The prognosis of patients with advanced-stage DLBCL is usually poor with frequen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Chenxi, Ni, Huimin, Wang, Zhina, Ji, Binbin, Wang, Bo, Shi, Xiaoli, Wu, Wanna, Liu, Nian, Gu, Ying, Ma, Dongshen, Liu, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551569/ https://www.ncbi.nlm.nih.gov/pubmed/34721544 http://dx.doi.org/10.3389/fgene.2021.756784

Ejemplares similares

Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx
por: Ma, Dongshen, et al.
Publicado: (2022)

Exploring milk loss and variability during environmental perturbations across lactation stages as resilience indicators in Holstein cattle
por: Wang, Ao, et al.
Publicado: (2022)

Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK(-) ALCL vs. CD30(high) PTCL, NOS
por: Xiang, Chenxi, et al.
Publicado: (2023)

Systematic Analysis of Competing Endogenous RNA Networks in Diffuse Large B-Cell Lymphoma and Hodgkin’s Lymphoma
por: Kang, Juanjuan, et al.
Publicado: (2020)

Modularized Perturbation of Alternative Splicing Across Human Cancers
por: Du, Yabing, et al.
Publicado: (2019)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022)

Corrigendum: Modularized Perturbation of Alternative Splicing Across Human Cancers
por: Du, Yabing, et al.
Publicado: (2019)

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Editorial: Artificial Intelligence in Bioinformatics and Drug Repurposing: Methods and Applications
por: Zheng, Pan, et al.
Publicado: (2022)

An Autophagy-Related Gene Signature can Better Predict Prognosis and Resistance in Diffuse Large B-Cell Lymphoma
por: Zhou, Xuan, et al.
Publicado: (2022)

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Hypoxia-related tumor environment correlated with immune infiltration and therapeutic sensitivity in diffuse large B-cell lymphoma
por: Liu, Chen, et al.
Publicado: (2022)

Network Crosstalk as a Basis for Drug Repurposing
por: Guala, Dimitri, et al.
Publicado: (2022)

Structural Equation Modeling of In silico Perturbations
por: Li, Jianying, et al.
Publicado: (2021)

A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma
por: Xu, Hong, et al.
Publicado: (2022)

Corrigendum: Network Crosstalk as a Basis for Drug Repurposing
por: Guala, Dimitri, et al.
Publicado: (2022)

Mutational signatures representative transcriptomic perturbations in hepatocellular carcinoma
por: Wu, Qiong, et al.
Publicado: (2022)

Integrative analysis of a necroptosis-related gene signature of clinical value and heterogeneity in diffuse large B cell lymphoma
por: Pan, Yu-Biao, et al.
Publicado: (2022)

Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
por: Feng, Pengcheng, et al.
Publicado: (2021)

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases
por: Challa, Anup P., et al.
Publicado: (2021)

Combined multiomics analysis reveals the mechanism of CENPF overexpression-mediated immune dysfunction in diffuse large B-cell lymphoma in vitro
por: Yang, Dan, et al.
Publicado: (2022)

Whole-Genome/Exome Sequencing Uncovers Mutations and Copy Number Variations in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
por: Zhu, Qiong, et al.
Publicado: (2022)

Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell Lymphoma
por: Pan, Mengmeng, et al.
Publicado: (2021)

Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapy
por: Li, Zhe, et al.
Publicado: (2022)

Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing
por: Gao, Fan, et al.
Publicado: (2021)

Biomarker-driven drug repurposing on biologically similar cancers with DNA-repair deficiencies
por: Munj, Seeya Awadhut, et al.
Publicado: (2022)

Detection of Echinococcus multilocularis in repurposed environmental DNA samples from river water
por: Mori, Kensuke, et al.
Publicado: (2023)

Cotton Duplicated Genes Produced by Polyploidy Show Significantly Elevated and Unbalanced Evolutionary Rates, Overwhelmingly Perturbing Gene Tree Topology
por: Meng, Fanbo, et al.
Publicado: (2020)

Editorial: Perturbation of RNA Binding Protein Regulation in Cancer
por: Li, Yongsheng, et al.
Publicado: (2021)

Massive Transcriptional Perturbation in Subgroups of Diffuse Large B-Cell Lymphomas
por: Rosolowski, Maciej, et al.
Publicado: (2013)

Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
por: Turanli, Beste, et al.
Publicado: (2019)

The rs78378222 prevalence and the copy loss of the protective allele A in the tumor tissue of diffuse large B-cell lymphoma
por: Voropaeva, Elena N., et al.
Publicado: (2020)

Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions
por: Manson, Lisanne E. N., et al.
Publicado: (2023)

Edgetic Perturbations Contribute to Phenotypic Variability in PEX26 Deficiency
por: Lotz-Havla, Amelie S., et al.
Publicado: (2021)

Identification of a Five-Gene Prognostic Model and Its Potential Drug Repurposing in Colorectal Cancer Based on TCGA, GTEx and GEO Databases
por: Yang, Feng, et al.
Publicado: (2021)

Totoro: Identifying Active Reactions During the Transient State for Metabolic Perturbations
por: Galvão Ferrarini, Mariana, et al.
Publicado: (2022)

Applying differential network analysis to longitudinal gene expression in response to perturbations
por: Xue, Shuyue, et al.
Publicado: (2022)

Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma
por: Zhao, Yang, et al.
Publicado: (2022)

Diffuse large B-cell lymphoma with continuously elevated immunoglobulin M following treatment: a case report with pathologic, immunophenotypic, and molecular analyses
por: Xiao, Fei, et al.
Publicado: (2023)

Polycomb repressive complex 2 controls cardiac cell fate decision via interacting with RNA: Promiscuously or well-ordered
por: Wang, Gang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0c13i8ff0ns5h953l65agi9ng4